0 01/01/2025 31/12/2025 2025-12-31 false false false false false false false true false false true false false false false true false false No description of principal activities is disclosed 2025-01-01 Sage Accounts Production 25.0 - FRS102_2025 xbrli:pure xbrli:shares iso4217:GBP 16137861 2025-01-01 2025-12-31 16137861 2025-12-31 16137861 2024-12-31 16137861 bus:RegisteredOffice 2025-01-01 2025-12-31 16137861 bus:Director1 2025-01-01 2025-12-31 16137861 bus:Director2 2025-01-01 2025-12-31 16137861 core:WithinOneYear 2025-12-31 16137861 bus:Micro-entities 2025-01-01 2025-12-31 16137861 bus:AuditExempt-NoAccountantsReport 2025-01-01 2025-12-31 16137861 bus:SmallCompaniesRegimeForAccounts 2025-01-01 2025-12-31 16137861 bus:PrivateLimitedCompanyLtd 2025-01-01 2025-12-31 16137861 bus:FullAccounts 2025-01-01 2025-12-31
Company registration number: 16137861
H & S Therapies Ltd
Trading as H & S Therapies
Unaudited filleted financial statements
31 December 2025
H & S Therapies Ltd
Contents
Directors and other information
Statement of financial position
H & S Therapies Ltd
Directors and other information
Directors Mr Sarfraz Ejaz
Mrs Hina Sarwar
Company number 16137861
Registered office 71-75, Shelton Street,
Covent Garden,
London
WC2H 9JQ
H & S Therapies Ltd
Statement of financial position
31 December 2025
2025
£
Creditors: amounts falling due within one year ( 7,263)
_______
Net current liabilities ( 7,263)
_______
Total assets less current liabilities ( 7,263)
_______
Net liabilities ( 7,263)
_______
Capital and reserves ( 7,263)
_______
H & S Therapies Ltd
Year ended 31 December 2025
For the year ending 31 December 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
Directors responsiblities:
- The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476.
- The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
The financial statements have been prepared in accordance with the micro-entity provisions and have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.
These financial statements were approved by the board of directors and authorised for issue on 03 September 2026 , and are signed on behalf of the board by:
Mr Sarfraz Ejaz
Director
Company registration number: 16137861
The company is a private company limited by shares, registered in United Kingdom.